Paymaneh D. Malihi

Anterior gradient 2 (AGR2): Blood‐based biomarker elevated in metastatic prostate cancer associated with the neuroendocrine phenotype

D. Ruderman, M. Gross, Yixin Wang, 2013, The Prostate.

Clonal diversity revealed by morphoproteomic and copy number profiles of single prostate cancer cells at diagnosis.

J. Hicks, B. Knudsen, I. Garraway, 2018, Convergent science physical oncology.

Prostate Cancer Disseminated Tumor Cells are Rarely Detected in the Bone Marrow of Patients with Localized Disease Undergoing Radical Prostatectomy across Multiple Rare Cell Detection Platforms

K. Pienta, P. Nelson, Jun Luo, 2018, The Journal of urology.

Large Extracellular Vesicle Characterization and Association with Circulating Tumor Cells in Metastatic Castrate Resistant Prostate Cancer

J. Hicks, C. Logothetis, P. Corn, 2021, Cancers.

Single-Cell Circulating Tumor Cell Analysis Reveals Genomic Instability as a Distinctive Feature of Aggressive Prostate Cancer

J. Hicks, N. Navin, C. Logothetis, 2020, Clinical Cancer Research.

JUN-Mediated Downregulation of EGFR Signaling Is Associated with Resistance to Gefitinib in EGFR-mutant NSCLC Cell Lines

P. Mallick, D. Agus, J. Katz, 2017, Molecular Cancer Therapeutics.

Platelet-Coated Circulating Tumor Cells Are a Predictive Biomarker in Patients with Metastatic Castrate-Resistant Prostate Cancer

P. Corn, A. Zurita, P. Kuhn, 2021, Molecular Cancer Research.

Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis

M. Gross, P. Mallick, J. Katz, 2018, Oncogene.

Multiplex protein detection on circulating tumor cells from liquid biopsies using imaging mass cytometry.

Peter Kuhn, James Hicks, Christopher Logothetis, 2018, Convergent science physical oncology.